Frontiers of commercial biotechnology. US and Japanese potential in a new industry

Document Type

Article

Publication Date

1-1-1987

Abstract

With their godlike ability to alter life and cure disease, the new biotechnologies have moved swiftly out of the laboratory and into various scientific and commercial applications. The small, innovative biotechnology firm has been the principal vehicle for the transition and it has been resoundingly supported by US venture capital and equity markets. Wall Street's support, however, could quickly evaporate, especially if major advances against cancer and AIDS are not soon forthcoming. With increasing Japanese interest in this field, there could be major industrial changes at the frontiers of commercial biotechnology. © 1987.

Publication Title

Futures

First Page Number

528

Last Page Number

544

DOI

10.1016/0016-3287(87)90062-0

This document is currently not available here.

Share

COinS